Navigation Links
Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes
Date:3/2/2011

Intensive adherence counseling around the time of HIV treatment initiation significantly reduces poor adherence and virologic treatment failure in sub-Saharan Africa, according to a recent study in PLoS Medicine by Dr. Michael Chung, assistant professor of Global Health at University of Washington, who works at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya.

The study published March 1 also found that using an alarm device has no effect on adherence counseling.

The findings of this study define an adherence counseling protocol that is effective and highly relevant to other HIV clinics caring for large numbers of patients in sub-Saharan Africa. As poor adherence to HIV treatment can lead to drug resistance and inadequate treatment of HIV, it is necessary to identify adherence interventions that are inexpensive and proven to be effective in resource-limited settings. The study complements a recent study on cell-phone strategies to increase adherence to HIV treatment published in Lancet 2010, which Chung also contributed as a co-author.

Chung helped the Coptic Hospital in Kenya establish the Hope Clinic, a free HIV care and treatment clinic. In 2004, this relationship led to a collaboration between the University of Washington and the Coptic Mission to provide free HIV care and treatment to Kenyans with support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). By 2010, more than 16,000 HIV-infected Kenyans have received medical treatment at the Coptic Hope Centers for Infectious Diseases.

In this recent study, the authors randomized 400 patients who were newly diagnosed with HIV and had never before taken antiretroviral therapy to receive adherence counseling alone; alarm device alone; both adherence counseling and alarm device together; and a control group that received neither adherence counseling nor alarm device.

Patients had baseline blood levels and then every six months for the duration of the study18 months. After starting HIV treatment, patients returned to the study clinic every month with their pill bottles for the study pharmacist to count and recorded the number of pills remaining in the bottle.

Patients receiving adherence counseling were 29 percent less likely to experience poor adherence compared to those who received no counseling. Furthermore, those receiving intensive early adherence counseling were 59 percent less likely to experience viral failure. However, there was no significant difference in mortality or significant differences in CD4 counts at 18 months follow-up between those who received counseling and those who did not. There were also no significant differences in adherence, time to viral failure, mortality, or CD4 counts in patients who received alarm devices compared to those who did not.

The authors conclude: "As antiretroviral treatment clinics expand to meet an increasing demand for HIV care in sub-Saharan Africa, adherence counseling should be implemented to decrease the development of treatment failure and spread of resistant HIV."


'/>"/>

Contact: Michael Chung
mhchung@uw.edu
206-543-4278
University of Washington - Health Sciences/UW News, Community Relations & Marketing
Source:Eurekalert

Related medicine news :

1. Study Finds Smoking Linked to Breast Cancer Risk
2. Heart Devices Not Tested Enough in Women: Study
3. Study Rates Success of Corneal Transplants in Kids
4. Half of U.S. Men Infected With HPV, Study Reveals
5. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
6. Study: Happiness improves health and lengthens life
7. New study: Medical and financial impact of drug-related poisonings treated in US EDs
8. Study links vitamin D to lung cancer survival
9. Global ISU study: Invasive species widespread, but not more than at home range
10. Sugary Drinks Might Raise Hypertension Risk: Study
11. Hospital use of virtual colonoscopy is on the rise, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines device ... business. , Mirroring360 Pro enables educators, business professionals and individuals to stream or ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President ... are preparing for how his administration could impact the employee benefits industry. James ... changes are most likely to make it through Congress. His discussion will focus ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like to ... a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, ... offers this revolutionary treatment with or without a referral. , Wilckodontics is ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology: